Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05471908

Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial

Compare the effectiveness of automatic vs as-needed (PRN) post-hospitalization follow-up for children who are hospitalized for common infections.

Recruiting

Interested in participating?

Request Info

Key information

Age range

Up to 18 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Phoenix Children's Hospital, Phoenix, Arizona, United States

Loading trial locations.

About this study

BACKGROUND:

Automatic post-hospitalization follow-up visits are commonly recommended by hospital-based pediatricians. The intuitive appeal of automatic follow-up visits is that they might decrease hospital readmissions and promote continuity of care. However, automatic follow-up visits result in missed work for parents, missed school for children, and expenses like co-pays and transportation costs. The principal alternative strategy to automatic follow-up is PRN (pro re nata, "as-needed") follow-up, a patient and family-centered approach that empowers parents to monitor their child's symptoms and decide if a follow-up visit is necessary.

OBJECTIVE:

Compare the effectiveness of automatic vs as-needed (PRN) post-hospitalization follow-up for children who are hospitalized for common infections.

DESIGN:

The Follow-up Automatically vs As-Needed Comparison (FAAN-C, or "fancy") trial is a multicenter randomized controlled trial

POPULATION:

Children hospitalized for pneumonia, skin and soft tissue infection, acute gastroenteritis, or urinary tract infection will be eligible for enrollment.

EXPERIMENTAL INTERVENTION:

Randomization to a recommendation for PRN post-hospitalization follow-up

CONTROL INTERVENTION:

Randomization to a recommendation for automatic post-hospitalization follow-up

OUTCOMES:

The primary outcome is hospital readmission within 14 days of discharge. Secondary outcomes are medical interventions and child health-related quality of life. Exploratory outcomes are cost burden, child time, parent time, symptom duration, total additional ambulatory visits, non-primary care ambulatory visits, parent self-efficacy, parent anxiety, satisfaction with care, telephone and electronic communications with medical providers, well-child visits, immunizations, usual place of medical care, and medical interventions related to the index infection. Safety outcomes are medical errors and hospital readmissions related to the index infection.

TRIAL SIZE:

A total of 2,674 patients (1,337 patients in each group) will be randomized, providing 90% power to demonstrate non-inferiority of a recommendation for PRN follow-up compared to a recommendation for automatic follow-up.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age <18 years at the time of randomization
  • Hospitalization due to a primary diagnosis of pneumonia, skin and soft tissue infection, acute gastroenteritis, or urinary tract infection.
  • Parent speaks English or Spanish.

Exclusion criteria

  • Presence of a comorbid disease that is both chronic and complex
  • Principal disease required surgical intervention (beyond superficial incision and drainage)
  • Immunodeficiency
  • A well-child check-up or post-hospitalization follow-up visit is already scheduled within 7 days of hospital discharge
  • Parent or participant strongly prefers PRN or automatic follow-up
  • A medical provider feels strongly that a post-hospitalization follow-up visit is needed within 7 days of hospital discharge
  • Sibling concurrently hospitalized
  • Unable to identify a clinic where the participant would receive any needed post-hospitalization follow-up
  • Diagnosis of pneumonia complicated by:

o Receiving a chest tube

  • Diagnosis of urinary tract infection complicated by:
  • History of neurogenic bladder or urologic surgery
  • Renal imaging anticipated within 7 days of hospital discharge
  • Renal abscess
  • Diagnosis of skin and soft tissue infection complicated by:
  • Chronic wound
  • Postoperative infection
  • Predisposition to poor wound healing
  • Discharging with a drain in place
  • Complicated by necrotizing fasciitis or toxic shock syndrome
  • Diagnosis of gastroenteritis complicated by:
  • Hemolytic uremic syndrome

Treatment and study plan

As-needed follow up

Behavioral

At hospital discharge, participant receives a recommendation for PRN follow-up. Recommendation informs participant that scheduling a follow-up visit is not needed at discharge and suggests that participant follow symptoms after discharge to decide if a visit is ultimately needed or not.

Other names: PRN (pro re nata)

Automatic follow-up

Behavioral

At hospital discharge, participant receives a recommendation for automatic follow-up. Recommendation instructs participant to schedule a follow-up visit and attend the visit even if symptoms get better.

Primary outcomes

  1. Hospital readmission

    Time frame: Within 14 days of hospital discharge

    The proportion of participants who experience a hospital readmission within 14 days of their index hospital discharge.

Secondary outcomes

  1. Medical interventions

    Time frame: Within 14 days of hospital discharge

    The proportion of participants who receive either a laboratory test, imaging test, or a new medication within 14 days of hospital discharge

  2. Child health-related quality of life

    Time frame: 7 days after hospital discharge

    Mean health-related quality of life score 7 days after hospital discharge, measured by the Impact on Activities and Routines instrument.

Other outcomes

  1. Cost burden

    Time frame: Within 14 days of hospital discharge

    Mean total costs to parents (missed income and expenses) related to the participant's illness within 14 days of hospital discharge, measured by the cost burden survey.

  2. Child time

    Time frame: Within 14 days of hospital discharge

    Mean number of hours of school or daycare missed by the participant within 14 days of hospital discharge as a result of their medical needs

  3. Parent time

    Time frame: Within 14 days of hospital discharge

    Mean number of hours spent away from responsibilities (work or non-work related) by parents within 14 days of hospital discharge as a result of their child's medical needs

  4. Symptom duration

    Time frame: Within 7 days of hospital discharge

    Proportion of participants who have completely recovered from their infection at 7 days after hospital discharge

  5. Total additional ambulatory visits

    Time frame: Within 30 days of hospital discharge

    Mean number of ambulatory visits (in-person or via telehealth) that a participant attends, apart from the post-hospitalization follow-up visit, within 30 days of hospital discharge; Ambulatory visits include clinic, urgent care, and emergency department (not resulting in hospital admission) visits.

  6. Non-primary care ambulatory visits

    Time frame: Within 30 days of hospital discharge

    Mean number of ambulatory visits (in-person or via telehealth) to non-primary care providers, within 30 days of hospital discharge; Non-primary care providers will include all providers outside of the clinic that families identify as their primary care clinic.

  7. Parent self-efficacy

    Time frame: 7 days after hospital discharge

    Mean self-efficacy score 7 days after hospital discharge, measured by the PROMIS self-efficacy short form.

  8. Parent anxiety

    Time frame: 7 days after hospital discharge

    Mean anxiety score 7 days after hospital discharge, measured by the PROMIS anxiety short form.

  9. Satisfaction with care

    Time frame: 7 days after hospital discharge

    Proportion of participants who report agreeing or strongly agreeing with the statement, "I am satisfied with the medical care my child has received since hospital discharge," 7 days after hospital discharge

  10. Telephone and electronic communications with medical providers

    Time frame: Within 14 days of hospital discharge

    Mean number of telephone and electronic (excluding telehealth visits) communications with a medical provider within 14 days of hospital discharge

  11. Well-child visits

    Time frame: Within 6 months of hospital discharge

    Proportion of participants who attend a well-child visit within Proportion of participants who attend a well-child visit within 6 months of hospital discharge

  12. Immunizations

    Time frame: Within 6 months of hospital discharge

    Proportion of participants who receive an immunization within 6 months of hospital discharge

  13. Usual place of medical care

    Time frame: Within 6 months of hospital discharge

    Proportion of participants who report having a usual place of medical care 6 months after hospital discharge

  14. Medical interventions related to the index infection

    Time frame: Within 14 days of hospital discharge

    Proportion of participants who receive either a laboratory test, imaging test, or a new medication related to the index infection within 14 days of hospital discharge

  15. Medical errors

    Time frame: Within 14 days of hospital discharge

    Proportion of parents who report that their child experienced a medical error within 14 days of hospital discharge, measured by the Family Safety Interview

  16. Hospital readmissions related to the index infection

    Time frame: Within 14 days of hospital discharge

    Proportion of participants who experience a hospital readmission related to the index infection within 14 days of hospital discharge

Study contacts

Contact information is provided by the study sponsor or research team.

Eric Coon, MD, MS

CONTACT

[email protected]

801-587-2160

Liz Rodriquez

CONTACT

[email protected]

Sponsors and collaborators

Lead sponsor

University of Utah

Other

Collaborators

  • Patient-Centered Outcomes Research Institute

Registry information

Official study title

The Follow-up Automatically vs. As-Needed Comparison Trial

Acronym: FAAN-C

Important dates

Study start
2022
Primary completion
2027
Study completion
2028
First posted
Jul 25, 2022
Registry last updated
Dec 10, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.